OCLS

Oculus Innovative Sciences, Inc. Press Releases

$3.32
*  
0.05
 negative 
1.48%
Get OCLS Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation
4/9/2014 8:08:00 AM - GlobeNewswire

Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO
4/2/2014 8:08:00 AM - GlobeNewswire

Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
3/27/2014 8:08:00 AM - GlobeNewswire

Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
3/26/2014 1:10:00 PM - PR Newswire

Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
2/27/2014 8:08:00 AM - GlobeNewswire

Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering
2/21/2014 10:00:00 PM - GlobeNewswire

Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico
2/19/2014 8:08:00 AM - GlobeNewswire

Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014
2/13/2014 4:05:00 PM - GlobeNewswire

Oculus Innovative Sciences Announces Completion of Agreements Required for IPO by Company's Subsidiary, Ruthigen, Inc.
2/6/2014 4:05:00 PM - GlobeNewswire

Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne
2/4/2014 8:08:00 AM - GlobeNewswire

Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call
1/30/2014 8:08:00 AM - GlobeNewswire